SV

Street Verdict

Analyst Scorecard

A record of what Rajesh Palviya said publicly, with the source. Not advice.

Pending — not yet graded
“Bullish on Natco Pharma Ltd, recommending to buy, hold, and accumulate. The stock decisively surpassed its three-week resistance zone of ₹1,275 with huge volumes, indicating a short-term trend reversal. Expected upside is ₹1,420-1,460, with downside support at ₹1,275-1,225.”

Rajesh Palviya’s track record (trackable calls only): 95 graded calls · 95% CI 46–65%

Natco Pharma LtdBullishCalled 07 Feb 2025
Verdict:PENDING

How this conditional call is judged

A conditional call says nothing until a daily close goes beyond a level the quote states. The first side to fire is judged on its own target, which has to be reached on a close. If neither side fires within the window, or the side that fires has no target of its own, the call is not graded and counts toward no hit rate.

Waiting: no close has gone beyond either level yet.

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Rajesh Palviya’s full track record